![James M. Roach](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James M. Roach
Chief Tech/Sci/R&D Officer at
CLEMENTIA PHARMACEUTICALS INC
Profile
James M.
Roach currently works at Clementia Pharmaceuticals, Inc., as Executive Vice-President-Research & Development.
Dr. Roach also formerly worked at Sumitomo Pharma America, Inc., as Senior Vice President-Medical Affairs from 2002 to 2008, Millennium Pharmaceuticals, Inc., as Head-Medical Affairs & Clinical Research, LeukoSite, Inc., as Head-Medical Affairs, Momenta Pharmaceuticals, Inc., as Chief Medical Officer & Senior VP-Development from 2011 to 2016, Astra USA, Inc., as Head-Medical Affairs, Harvard Medical School, as Assistant Clinical Professor, Veristat LLC, as Chief Medical Officer, and Pulmatrix, Inc., as Chief Medical Officer from 2017 to 2019.
Dr. Roach received his undergraduate degree from College of the Holy Cross (Massachusetts) and doctorate degree from Georgetown University School of Medicine.
James M. Roach active positions
| Companies | Position | Start |
|---|---|---|
| CLEMENTIA PHARMACEUTICALS INC | Chief Tech/Sci/R&D Officer | - |
Former positions of James M. Roach
| Companies | Position | End |
|---|---|---|
| PULMATRIX, INC. | Chief Tech/Sci/R&D Officer | 07/03/2019 |
| MOMENTA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 28/11/2016 |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Chief Tech/Sci/R&D Officer | 31/01/2008 |
Astra USA, Inc. | Chief Tech/Sci/R&D Officer | - |
LeukoSite, Inc.
 LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of cancer and inflammatory diseases | Chief Tech/Sci/R&D Officer | - |
Training of James M. Roach
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
53
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
LeukoSite, Inc.
LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of cancer and inflammatory diseases | Health Technology |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases | Health Technology |
College of the Holy Cross (Massachusetts)
 College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astra USA, Inc. | |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Veristat LLC
 Veristat LLC BiotechnologyHealth Technology Operates as a CRO and consulting firm that helps life sciences companies | Health Technology |
Georgetown University School of Medicine
 Georgetown University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clementia Pharmaceuticals, Inc.
 Clementia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops treatments for patients suffering from bone disorders and other diseases | Health Technology |
Pulmatrix, Inc.
 Pulmatrix, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for pulmonary disease | Health Technology |
- Stock Market
- Insiders
- James M. Roach
